Trademarkia Logo

Australia

AU$
DERZUVUS
Protected: Registered/protected

Last updated on 24 Aug 2024

Owner Info

Basilea Pharmaceutica International AG, Allschwil

2451 Croasdaile Farm Parkway,

Suite 109, UNITED STATES OF AMERICA

Serial Number

2153177 filed on 18 Nov 2020

Correspondent

Gliobastoma Foundation, Inc.

2451 Croasdaile Farm Parkway,,

Suite 109,

UNITED STATES OF AMERICA

DERZUVUS

Classification Information


Class [005]
Pharmaceutical products and preparations for human use; pharmaceutical products and preparations for the treatment of cancer.

Mark Details


Serial Number

2153177

Registered On

18 Nov 2020

Renewal On

18 Nov 2030

Mark Type

WORD

Priority Claim (Convention Details)


Date

21 May 2020

Mark Type

CH

Legal History


Show more

Status DateAction Taken
24th Aug 2024Full Assignment - Subsequent Owner Registered Published
22nd Aug 2024Full Assignment Requested
8th Aug 2024Amendment to International Registration Contact Requested
25th Aug 2022Amendment to Amend Owner Requested
28th Apr 2021International Registration in Australia Protected correspondence sent
27th Apr 2021International Registration in Australia Protected correspondence sent
27th Apr 2021IP Right Registration Published
27th Apr 2021Status change to Registered/Protected
19th Feb 2021Application Accepted correspondence sent
18th Feb 2021Application Accepted correspondence sent